Trademark: 97236725
Word
HEZKUE
Status Date
Friday, August 2, 2024
Filing Date
Tuesday, January 25, 2022
Published for Opposition
Tuesday, June 13, 2023
5 Pharmaceutical compounds, namely, pharmaceutical preparations for the treatment of erectile dysfunction and for the treatment of hypertension; pharmaceutical preparations, namely, sildenafil for the treatment of erectile dysfunction and for the treatment of hypertension; pharmaceutical preparations in the nature of an oral spray formulation of sildenafil for the treatment of erectile dysfunction and for the treatment of hypertension; a drug delivery device prefilled with pharmaceutical products for the treatment of erectile dysfunction and for the treatment of hypertension
Nov 3, 2022
Assigned To Examiner
Jan 28, 2022
New Application Entered
Jan 28, 2022
New Application Office Supplied Data Entered
Nov 4, 2022
Non-Final Action Written
Nov 4, 2022
Non-Final Action E-Mailed
Nov 4, 2022
Notification Of Non-Final Action E-Mailed
May 4, 2023
Teas Response To Office Action Received
May 4, 2023
Correspondence Received In Law Office
May 4, 2023
Teas/Email Correspondence Entered
May 24, 2023
Notification Of Notice Of Publication E-Mailed
Jun 13, 2023
Published For Opposition
Jun 13, 2023
Official Gazette Publication Confirmation E-Mailed
May 8, 2023
Approved For Pub - Principal Register
Feb 7, 2024
Sou Teas Extension Received
Aug 8, 2023
Noa E-Mailed - Sou Required From Applicant
Feb 7, 2024
Sou Extension 1 Filed
Feb 7, 2024
Sou Extension 1 Granted
Feb 9, 2024
Notice Of Approval Of Extension Request E-Mailed
Aug 2, 2024
Sou Teas Extension Received
Aug 2, 2024
Notice Of Approval Of Extension Request E-Mailed
Aug 2, 2024
Sou Extension 2 Granted
Aug 2, 2024
Sou Extension 2 Filed
Trademark Alertz updated from USPTO on 2030-01-24
